Navigation Links
Scientists notch a win in war against antibiotic-resistant bacteria
Date:2/4/2013

Boston, MA, February 4, 2013 A team of scientists just won a battle in the war against antibiotic-resistant "superbugs" -- and only time will tell if their feat is akin to the bacterial "Battle of Gettysburg" that turns the tide toward victory.

They won this particular battle, or at least gained some critical intelligence, not by designing a new antibiotic, but by interfering with the metabolism of the bacterial "bugs" E. coli in this case and rendering them weaker in the face of existing antibiotics, as reported today in Nature Biotechnology.

It's the "kick 'em when they're down" style of fighting, and the team from Harvard's Wyss Institute for Biologically Inspired Engineering and Boston University used sophisticated computer modeling and biotechnology as their weapons of choice.

"We are in critical need for novel strategies to boost our antibiotic arsenal," said senior author and Wyss Core Faculty member Jim Collins, Ph.D., a pioneer of synthetic biology who is also the William F. Warren Distinguished Professor at Boston University, where he leads the Center for BioDynamics. "With precious few new antibiotics in the pipeline, we are finding new ways to harness and exploit certain aspects of bacterial physiology."

In this case, the team targeted a little understood but key part of bacterial metabolism called ROS production.

ROS, or "reactive oxygen species," include molecules like superoxide and hydrogen peroxide that are natural byproducts of normal metabolic activity. Bacteria usually cope just fine with them, but too many can cause serious damage or even kill the cell. In fact, Collins' team revealed a few years ago the true antibiotic "modis operandi": they kill bacteria in part by ramping up ROS production.

The precise genetic mechanisms by which E. coli produces ROS remain elusive, Collins said, so his team adopted a standard computer model that maps out the way scientists currently understand E. coli metabolism. Collins' team began by adding to this "system-level" metabolic model hundreds of reactions that are known to increase ROS production. Then they deleted various genes to see which were involved in ROS production, honed in on the suspected targets after running thousands of computer simulations, and validated the model in the laboratory -- achieving 80-90% agreement with the model-based predictions.

"The next challenge was to determine if increasing the ROS production by the cell itself would render it more susceptible to death by oxidative, ergo, antibiotic attack," Collins said -- and it did. The team deleted a series of genes that led to increased ROS production in the cell, added different antibiotics and biocides such as bleach known cell-killers by way of increasing ROS production and the cells died at a much higher rate than the cells without the deleted genes. In short, by interfering with the bacterial metabolism, the antibiotics and biocides were even more lethal to the cells.

"There is no magic bullet for the global health crisis we're experiencing in terms of antibiotic-resistant bacteria," said Don Ingber, M.D., Ph.D., Wyss Founding Director, "and yet there is tremendous hope in the kinds of pioneering systems biology approaches Jim and his team are spearheading."

The team's next steps are to use molecular screening technologies to precisely identify molecules that boost ROS production, Collins said, and to test the approach used in this E. coli study on other kinds of bacteria -- such as the mycobacteria responsible for tuberculosis, a potentially lethal lung disease.


'/>"/>

Contact: Kristen Kusek
kristen.kusek@wyss.harvard.edu
617-432-8266
Wyss Institute for Biologically Inspired Engineering at Harvard
Source:Eurekalert  

Related biology news :

1. Plant scientists at CSHL demonstrate new means of boosting maize yields
2. Listening to cells: Scientists probe human cells with high-frequency sound
3. A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans
4. Joslin scientists find first human iPSC from patients with maturity onset diabetes of the young
5. Scientists uncover previously unknown mechanism of memory formation
6. Scientists trick iron-eating bacteria into breathing electrons instead
7. Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists
8. Virginia Tech computer scientists develop new way to study molecular networks
9. UCI neuroscientists create fiber-optic method of arresting epileptic seizures
10. Scientists discover needle in a haystack for muscular dystrophy patients
11. Just add water: How scientists are using silicon to produce hydrogen on demand
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists notch a win in war against antibiotic-resistant bacteria
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
(Date:12/7/2016)... 7, 2016   Veridium , a leader ... of new CEO James Stickland . Stickland, ... of experience, has served in senior executive roles ... specialized in expanding a pipeline of venture capital ... most recently served as managing director of U.K.-based ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock ... Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated to ... 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... ... 11, 2017 , ... Ovation Fertility™ Genetics now offers a ... screening (PGS). , “Our genetics and IVF teams are recognized experts in both ... Amy Jones, M.S., ELD (ABB) , who has worked with or directed ...
(Date:1/11/2017)... , Jan. 11, 2017  Brian Mehling, M.D., world-renowned ... of Blue Horizon International (BHI), will be attending the ... Davos from January 17-20, 2017. This will ... The theme of this year,s forum is ... 400 sessions will address strategies for fostering greater social ...
(Date:1/11/2017)... San Francisco, CA (PRWEB) , ... January 11, ... ... ongoing series of in-kind scientific grants to ground-breaking microbiome studies. Its most recent ... University School of Medicine, who will study the effect of long-term use of ...
Breaking Biology Technology: